What Sphera Funds Management Ltd. reported holding on Form 13F for the quarter ended Jun 30, 2026.
CIK 1496201 · Filed Aug 14, 2026
Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR
| 1.5M |
| +9.7% |
| $39.7M |
| 5.2% |
TSEMTower Semiconductor Ltd | 108.3K | −25.7% | $28.2M | 3.7% |
SPDR SERIES TRUSTST STR SP BIOTPut option | 150K | New | $23.7M | 3.1% |
SNDXSyndax Pharmaceuticals Inc | 1M | +40.0% | $22.2M | 2.9% |
| 100K | New | $21.6M | 2.8% |
BIIBBiogen Inc. | 96.6K | +4.4% | $20.9M | 2.7% |
RAREUltragenyx Pharmaceutical Inc. | 588.5K | −27.3% | $19.6M | 2.6% |
BMRNBioMarin Pharmaceutical Inc | 328.6K | +134.8% | $18.8M | 2.5% |
CYTKCytokinetics Inc | 220K | +452.5% | $18.7M | 2.4% |
BBIOBridgeBio Pharma, Inc. | 245.3K | +0.0% | $18.3M | 2.4% |
COGTCogent Biosciences, Inc. | 459.3K | +10.3% | $17.8M | 2.3% |
NVMINova Ltd. | 25.2K | −52.8% | $13.7M | 1.8% |
INSMINSMED Inc | 118.8K | New | $12.7M | 1.7% |
MAZEMaze Therapeutics, Inc. | 417.6K | +83.7% | $12.5M | 1.6% |
AZNAstraZeneca PLC | 62.5K | ±0% | $11.9M | 1.5% |
SNYSanofi | 269.5K | ±0% | $11.5M | 1.5% |
HELPHelus Pharma Inc. | 1.6M | +64.2% | $10.7M | 1.4% |
LLYELI LILLY & Co | 8K | −11.1% | $9.6M | 1.3% |
MDGLMadrigal Pharmaceuticals, Inc. | 17.4K | +92.7% | $9.4M | 1.2% |
TRVITrevi Therapeutics, Inc. | 499K | −13.1% | $9.3M | 1.2% |
ACADAcadia Pharmaceuticals Inc | 356.5K | +39.2% | $9M | 1.2% |
CLDXCelldex Therapeutics, Inc. | 240.9K | −1.1% | $9M | 1.2% |
RYTMRhythm Pharmaceuticals, Inc. | 80.4K | New | $8.9M | 1.2% |
| 100K | −61.4% | $8.5M | 1.1% |
ORICOric Pharmaceuticals, Inc. | 753K | +40.1% | $8.2M | 1.1% |
LRCXLAM Research Corp | 18.5K | New | $8M | 1% |
AMATApplied Materials Inc | 11K | New | $8M | 1% |
TNGXTango Therapeutics, Inc. | 254.3K | −26.0% | $7.9M | 1% |
NVSNovartis AG | 50K | +35.1% | $7.8M | 1% |
SOLAREDGE TECHNOLOGIES INCNOTE 2.250% 7/0 | 4M | ±0% | $7.7M | 1% |
VORVor Biopharma Inc. | 416.4K | +29.4% | $7.7M | 1% |
ABBVAbbVie Inc. | 30.3K | ±0% | $7.6M | 1% |
MRKMerck & Co., Inc. | 58.6K | +20.6% | $7.5M | 1% |
JNJJohnson & Johnson | 28.8K | ±0% | $7.3M | 1% |
IDYAIDEAYA Biosciences, Inc. | 196.4K | New | $7.3M | 1% |
IMTXImmatics N.V. | 720.1K | +3.4% | $7.3M | 1% |
NVCTNuvectis Pharma, Inc. | 382.9K | New | $7M | 0.9% |
PFEPfizer Inc | 286K | +53.8% | $6.9M | 0.9% |
HRMYHarmony Biosciences Holdings, Inc. | 176.7K | New | $6.4M | 0.8% |
XENEXenon Pharmaceuticals Inc. | 105K | −17.3% | $6.3M | 0.8% |
CLYMClimb Bio, Inc. | 483.7K | +15.4% | $6.3M | 0.8% |
ZBIOZenas BioPharma, Inc. | 230.8K | +7.7% | $5.9M | 0.8% |
NVONovo Nordisk a S | 120.7K | ±0% | $5.8M | 0.8% |
ELVNEnliven Therapeutics, Inc. | 112.8K | −26.4% | $5.7M | 0.7% |
PRLDPrelude Therapeutics Inc | 1M | +82.7% | $5.4M | 0.7% |
GSKGSK plc | 102K | −16.4% | $5.3M | 0.7% |
FBRXForte Biosciences, Inc. | 249.7K | +35.0% | $5.3M | 0.7% |
BIOABioAge Labs, Inc. | 213.7K | +147.0% | $5.2M | 0.7% |
SRRKScholar Rock Holding Corp | 94.3K | ±0% | $5.2M | 0.7% |
MSLESatellos Bioscience Inc. | 652.6K | +33.4% | $5.1M | 0.7% |
PALIPalisade Bio, Inc. | 2.3M | +30.2% | $4.7M | 0.6% |
ELDNEledon Pharmaceuticals, Inc. | 1.2M | −32.8% | $4.7M | 0.6% |
VSTVistra Corp. | 29.5K | New | $4.7M | 0.6% |
TLNTalen Energy Corp | 12.1K | New | $4.7M | 0.6% |
SVRASavara Inc | 756.2K | +2.3% | $4.7M | 0.6% |
IRONDisc Medicine, Inc. | 63.5K | +18.7% | $4.6M | 0.6% |
GLOBAL X FDSCLOUD COMPUTNG | 195.9K | New | $4.5M | 0.6% |
DYNDyne Therapeutics, Inc. | 199.6K | +24.3% | $4.4M | 0.6% |
RLAYRelay Therapeutics, Inc. | 233.8K | −42.7% | $4.4M | 0.6% |
AVTXAvalo Therapeutics, Inc. | 232.3K | New | $4.3M | 0.6% |
PMNProMIS Neurosciences Inc. | 325.6K | ±0% | $4.3M | 0.6% |
BCRXBiocryst Pharmaceuticals Inc | 422.1K | −51.3% | $4.2M | 0.6% |
RVMDRevolution Medicines, Inc. | 22.4K | −59.4% | $4.2M | 0.5% |
| 12.5K | New | $4.2M | 0.5% |
CABACabaletta Bio, Inc. | 1.3M | New | $4.1M | 0.5% |
GENBGenerate Biomedicines, Inc. | 245K | +32.4% | $4.1M | 0.5% |
ISHARES TR20 YR TR BD ETFCall option | 47K | ±0% | $4.1M | 0.5% |
MDWDMediWound Ltd. | 273.2K | ±0% | $4M | 0.5% |
ACOGAlpha Cognition Inc. | 545.8K | −3.8% | $3.9M | 0.5% |
WVEWave Life Sciences, Inc. | 638.3K | +16.4% | $3.7M | 0.5% |
CRVSCorvus Pharmaceuticals, Inc. | 245K | −1.2% | $3.7M | 0.5% |
OVIDOvid Therapeutics Inc. | 1.4M | −16.6% | $3.6M | 0.5% |
BBOTBridgeBio Oncology Therapeutics, Inc. | 461K | New | $3.5M | 0.5% |
CTMXCytomX Therapeutics, Inc. | 879K | +299.5% | $3.3M | 0.4% |
PRQRProQR Therapeutics N.V. | 1.8M | New | $3.3M | 0.4% |
ALNYAlnylam Pharmaceuticals, Inc. | 10.8K | New | $3.3M | 0.4% |
KURAKura Oncology, Inc. | 295K | −0.2% | $3.2M | 0.4% |
KODKodiak Sciences Inc. | 81.8K | −28.7% | $3.2M | 0.4% |
ORAOrmat Technologies, Inc. | 28K | −59.0% | $3.1M | 0.4% |
CTNMContineum Therapeutics, Inc. | 183.5K | +5.8% | $3M | 0.4% |
LRMRLarimar Therapeutics, Inc. | 926K | New | $2.8M | 0.4% |
IMMXImmix Biopharma, Inc. | 270K | New | $2.8M | 0.4% |
AMGNAmgen Inc | 7.5K | ±0% | $2.7M | 0.4% |
| 20K | New | $2.7M | 0.3% |
BHVNBiohaven Ltd. | 164.4K | −72.3% | $2.4M | 0.3% |
CEGConstellation Energy Corp | 9.9K | New | $2.4M | 0.3% |
VSTMVerastem, Inc. | 632.6K | +84.1% | $2.4M | 0.3% |
| 127.6K | New | $1.9M | 0.2% |
TENXTenax Therapeutics, Inc. | 120.2K | −11.6% | $1.7M | 0.2% |
TSHATaysha Gene Therapies, Inc. | 250K | New | $1.7M | 0.2% |
GPCRStructure Therapeutics Inc. | 28.6K | −43.7% | $1.5M | 0.2% |
UPBUpstream Bio, Inc. | 219.7K | −38.6% | $1.5M | 0.2% |
VYGRVoyager Therapeutics, Inc. | 427.6K | −9.0% | $1.5M | 0.2% |
ORGOOrganogenesis Holdings Inc. | 550K | ±0% | $1.3M | 0.2% |
IKTInhibikase Therapeutics, Inc. | 649.3K | New | $1.3M | 0.2% |
| 100K | New | $1.1M | 0.1% |
CURIS INCCOM | 99K | −95.0% | $1M | 0.1% |
STTKShattuck Labs, Inc. | 86.5K | −69.2% | $600K | 0.1% |
TRAXFirst Tracks Biotherapeutics, Inc. | 27.9K | New | $560.9K | 0.1% |
SKYESkye Bioscience, Inc. | 678.9K | ±0% | $470.7K | 0.1% |
TRAWTraws Pharma, Inc. | 398.5K | New | $336K | 0.1% |
EVMNEvommune, Inc. | 22.6K | −71.1% | $300.8K | 0.1% |
HOWLWerewolf Therapeutics, Inc. | 626.8K | ±0% | $225.6K | 0.1% |
APREAprea Therapeutics, Inc. | 270K | ±0% | $216.6K | 0.1% |
